Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.
暂无分享，去创建一个
H. Einsele | P. Kufer | P. Baeuerle | G. Riethmüller | G. Zugmaier | M. Kneba | M. Schaich | O. Ottmann | H. Horst | R. Bargou | D. Hoelzer | T. Burmeister | M. Brüggemann | T. Raff | N. Gökbuget | M. Stelljes | A. Viardot | D. Nagorsen | M. Topp | M. Klinger | M. Goebeler | S. Neumann | Margit Schmidt | E. Degenhard | R. Köhne-Volland | Evelyn Degenhard